Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
BMJ Case Reports
|
May 8, 2019
Visual loss in pregnancy
Caroline Annette Erika Bachmeier, Cameron Snell, Adam Morton
Breast Cancer Research : BCR
|
February 14, 2008
BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
Cameron Snell, Michael Krypuy, Ee Ming Wong, et al.
Pathology
|
January 29, 2022
Validation of EGFR mutation testing on cytological smears of lung cancer using the Idylla platform
Cameron Snell, Sam McManus, Kelly Robinson, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
December 7, 2023
The in situ transcriptomic landscape of breast tumour-associated and normal adjacent endothelial cells
Akhilandeshwari Ravichandran, James Monkman, Ahmed M Mehdi, et al.
Breast Cancer Research and Treatment
|
November 12, 2020
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer
Romain Tropée, Bárbara de la Peña Avalos, Madeline Gough, et al.
Cancer Medicine
|
October 25, 2013
Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Tom Donnem, Jiangting Hu, Mary Ferguson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 9, 2024
Development and Validation of a HER2-Low Focused Immunohistochemical Scoring System With High-Interobserver Concordance: The Australian HER2-Low Breast Cancer Concordance Study
Gelareh Farshid, Jane Armes, Benjamin Dessauvagie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 26, 2024
Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency
Gelareh Farshid, Jane Armes, Benjamin Dessauvagie, et al.
Chinese Journal of Cancer
|
February 14, 2016
Why some tumours trigger neovascularisation and others don't: the story thus far
Omanma Adighibe, Russell D Leek, Marta Fernandez-Mercado, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 11, 2017
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer
Mark N Adams, Joshua T Burgess, Yaowu He, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
BMJ Case Reports
|
May 8, 2019
Visual loss in pregnancy
Caroline Annette Erika Bachmeier, Cameron Snell, Adam Morton
Breast Cancer Research : BCR
|
February 14, 2008
BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
Cameron Snell, Michael Krypuy, Ee Ming Wong, et al.
Pathology
|
January 29, 2022
Validation of EGFR mutation testing on cytological smears of lung cancer using the Idylla platform
Cameron Snell, Sam McManus, Kelly Robinson, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
December 7, 2023
The in situ transcriptomic landscape of breast tumour-associated and normal adjacent endothelial cells
Akhilandeshwari Ravichandran, James Monkman, Ahmed M Mehdi, et al.
Breast Cancer Research and Treatment
|
November 12, 2020
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer
Romain Tropée, Bárbara de la Peña Avalos, Madeline Gough, et al.
Cancer Medicine
|
October 25, 2013
Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Tom Donnem, Jiangting Hu, Mary Ferguson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 9, 2024
Development and Validation of a HER2-Low Focused Immunohistochemical Scoring System With High-Interobserver Concordance: The Australian HER2-Low Breast Cancer Concordance Study
Gelareh Farshid, Jane Armes, Benjamin Dessauvagie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 26, 2024
Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency
Gelareh Farshid, Jane Armes, Benjamin Dessauvagie, et al.
Chinese Journal of Cancer
|
February 14, 2016
Why some tumours trigger neovascularisation and others don't: the story thus far
Omanma Adighibe, Russell D Leek, Marta Fernandez-Mercado, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 11, 2017
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer
Mark N Adams, Joshua T Burgess, Yaowu He, et al.
Page
of 3